Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 245-910-0 | CAS number: 23847-08-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2001-08-15 - 2001-09-21
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: well-documented GLP study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 001
- Report date:
- 2001
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
- Deviations:
- no
- GLP compliance:
- yes
- Remarks:
- UK Department of Health
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 1,1'-dithiobis[hexahydro-2H-azepin-2-one]
- EC Number:
- 245-910-0
- EC Name:
- 1,1'-dithiobis[hexahydro-2H-azepin-2-one]
- Cas Number:
- 23847-08-7
- Molecular formula:
- C12H20N2O2S2
- IUPAC Name:
- 1-[(2-oxoazepan-1-yl)disulfanyl]azepan-2-one
- Reference substance name:
- CLDS (Caprolactam disulfide)
- IUPAC Name:
- CLDS (Caprolactam disulfide)
- Details on test material:
- - Name of test material (as cited in study report): CLDS (Caprolactam disulfide)
- Substance type: organic
- Physical state: solid (off-white powder)
- Lot/batch No.: 0110079/007
- Storage condition of test material: room temperature, in the dark
- Other: data relating to the identity, purity and stability of the test material are the responsibility of the Sponsor.
Constituent 1
Constituent 2
Method
- Target gene:
- histidin- (S. typhimurium) / tryptophan- (E. coli)
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Details on mammalian cell type (if applicable):
- The Salmonella strains were obtained from the University of California at Berkeley on culture discs on 4 August 1995. All of the strains were stored at -196°C in a Statebourne liquid nitrogen freezer, model SXR 34. Prior to the master strains being used, characterisation checks were carried out to confirm the amino-acid requirement, presence of rfa, R factors and the spontaneous reversion rate. Prior to use, the master strains were checked for characteristics, viability and spontaneous reversion rate (all were found to be satisfactory).
In this assay, overnight sub-cultures of the appropriate coded stock cultures were prepared in nutrient broth and incubated at 37°C for approximately 10 hours. Each culture was monitored spectrophotometrically for turbidity with titres determined by viable count analysis on nutrient agar plates. - Additional strain / cell type characteristics:
- not specified
- Species / strain / cell type:
- E. coli WP2 uvr A
- Details on mammalian cell type (if applicable):
- The Escherichia coli strain WP2uvrA- was obtained from the British Industrial Biological Research Association on 17 August 1987. All of the strains were stored at -196°C in a Statebourne liquid nitrogen freezer, model SXR 34. Prior to the master strains being used, characterisation checks were carried out to confirm the amino-acid requirement, presence of rfa, R factors, uvrB or uvrA mutation and the spontaneous reversion rate. Prior to use, the master strains were checked for characteristics, viability and spontaneous reversion rate (all were found to be satisfactory).
In this assay, overnight sub-cultures of the appropriate coded stock cultures were prepared in nutrient broth and incubated at 37°C for approximately 10 hours. Each culture was monitored spectrophotometrically for turbidity with titres determined by viable count analysis on nutrient agar plates. - Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver homogenate metabolising system (10% liver S9 in standard co-factors).
- Test concentrations with justification for top dose:
- Mutation experiment 1: 15, 50, 150, 500, 1500 and 5000 μg/plate
Mutation experiment 2: 50 to 5000 μg/plate for Escherichia coli strain WP2uvrA- and 15 to 5000 μg/plate for the Salmonella tester strains (use of fresh cultures of the bacterial strains and fresh test material formulations)
An additional dose (15 μg/plate) was used to allow for the toxicity of the test material and to ensure there were a minimum of four non-toxic doses plated out. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: low water solubility
Controlsopen allclose all
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- N-ethyl-N-nitro-N-nitrosoguanidine
- Remarks:
- Migrated to IUCLID6: 3 μg/plate for TA100, 5 μg/plate for TA1535 and 2 μg/plate for WP2uvrA-
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- Remarks:
- Migrated to IUCLID6: 80 μg/plate for TA1537
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- Remarks:
- Migrated to IUCLID6: 0.2 μg/plate for TA98
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- other:
- Positive control substance:
- other: 2-Aminoanthracene, 1 μg/plate for TA100, 2 μg/plate for TA1535 and TA1537, 10 μg/plate for WP2uvrA-
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- other:
- Positive control substance:
- benzo(a)pyrene
- Remarks:
- Migrated to IUCLID6: 5 μg/plate for TA98
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
DURATION
- Exposure duration: 48 hours
SELECTION AGENT (mutation assays): no histidine or tryptophan supplemented, top agar
NUMBER OF REPLICATIONS: 3
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth
Test substance and controls:
The test material was accurately weighed and approximate half-log dilutions prepared in dimethyl sulphoxide by mixing on a vortex mixer and sonication for 15 minutes at 40°C on the day of each experiment.
Prior to use, the solvent was dried using molecular sieves (sodium alumino-silicate) ie 2 mm pellets with a nominal pore diameter of 4 x 10E-4 microns.
Vehicle and positive controls were used in parallel with the test material.
In addition, 2-Aminoanthracene (2AA) and Benzo(a)pyrene (BP), which are non-mutagenic in the absence of metabolising enzymes, were used in the series of plates with S9-mix.
S9-Mix:
S9 was prepared in-house on 28 April 2001 and 04 August 2001 from the livers of male Sprague-Dawley rats weighing ~ 250g. These had each orally received three consecutive daily doses of phenobarbitone/b-naphthoflavone (80/100 mg per kg per day) prior to S9 preparation. Before use, each batch of S9 was assayed for its ability to metabolise the indirect mutagens 2-Aminoanthracene and Benzo(a)pyrene. The S9 was stored at -196ºC.
The S9-mix was prepared immediately before use using sterilised co-factors and maintained on ice for the duration of the test. The S9-mix used in both experiments was shown to be sterile.
- S9: 5.0 ml
- 1.65 M KCl/0.4 M MgCl2: 1.0 mL
- 0.1 M Glucose-6-phosphate: 2.5 mL
- 0.1 M NADPH: 2.0 mL
- 0.1 M NADH: 2.0 mL
- 0.2 M Sodium phosphate buffer (pH 7.4): 25.0 mL
- Sterile distilled water: 12.5 mL
A 0.5 mL aliquot of S9-mix and 2 mL of molten, trace histidine or tryptophan supplemented, top agar was overlaid onto a sterile Vogel-Bonner Minimal agar plate in order to assess the sterility of the S9-mix. This procedure was repeated, in triplicate, on the day of each experiment.
Top agar was prepared using 0.6% Difco Bacto agar and 0.5% sodium chloride with 5 mL of 1.0 mM histidine and 1.0 mM biotin or 1.0 mM tryptophan solution added to each 100 mL of top agar. Vogel-Bonner Minimal agar plates were purchased from Fred Baker Scientific. - Evaluation criteria:
- The reverse mutation assay may be considered valid if the following criteria are met:
All tester strain cultures exhibit a characteristic number of spontaneous revertants per plate in the vehicle and untreated controls.
The appropriate characteristics for each tester strain have been confirmed, eg rfa cell-wall mutation and pkM101 plasmid R-factor etc.
All tester strain cultures should be in the approximate range of 1 to 9.9 x 10E9 bacteria per mL.
Each mean positive control value should be at least two times the respective vehicle control value for each strain, thus demonstrating both the intrinsic sensitivity of the tester strains to mutagenic exposure and the integrity of the S9-mix.
There should be a minimum of four non-toxic test material dose levels.
There should be no evidence of excessive contamination.
The test material should have induced a reproducible, dose-related and statistically (Dunnett's method of linear regression) significant increase in the revertant count in at least one strain of bacteria. - Statistics:
- no data on statistical methods employed was available.
Results and discussion
Test resultsopen allclose all
- Species / strain:
- other: TA 100 and WP2urvA-
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- No significant increases in the frequency of revertant colonies were recorded for any of the bacterial strains, with any dose of the test material, either with or without metabolic activation
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- The test material was toxic at and above 1500 and 5000 μg/plate to the strains of bacteria used, TA100 and WP2uvrA-, respectively.
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- not specified
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- No significant increases in the frequency of revertant colonies were recorded for any of the bacterial strains, with any dose of the test material, either with or without metabolic activation
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- The test material caused a visible reduction in the growth of the bacterial background lawn to the majority of the Salmonella tester strains, both with and without S9-mix, at 5000 μg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- No significant increases in the frequency of revertant colonies were recorded for any of the bacterial strains, with any dose of the test material, either with or without metabolic activation
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- The test material caused a visible reduction in the growth of the bacterial background lawn to the majority of the Salmonella tester strains, both with and without S9-mix, at 5000 μg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- No significant increases in the frequency of revertant colonies were recorded for any of the bacterial strains, with any dose of the test material, either with or without metabolic activation
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: no
RANGE-FINDING/SCREENING STUDIES:
The dose range was determined in a preliminary toxicity assay and was 15 to 5000 μg/plate in the first experiment. The experiment was repeated on a separate day using a similar dose range to Experiment 1, fresh cultures of the bacterial strains and fresh test material formulations. An additional dose (15 μg/plate) was used to allow for the toxicity of the test material and to ensure there were a minimum of four non-toxic doses plated out. The test material was toxic at and above 1500 and 5000 μg/plate to the strains of bacteria used, TA100 and WP2uvrA-, respectively. The test material formulation and S9-mix used in this experiment were both shown to be sterile.
COMPARISON WITH HISTORICAL CONTROL DATA: Yes and results for the negative controls (spontaneous mutation rates) were considered to be acceptable.
ADDITIONAL INFORMATION ON CYTOTOXICITY: the test material caused a visible reduction in the growth of the bacterial background lawn to the majority of the Salmonella tester strains, both with and without S9-mix, at 5000 μg/plate. No toxicity was observed to Escherichia coli strain WP2uvrA-. The test material was, therefore, tested up to the maximum recommended dose level of 5000 μg/plate. No test material precipitate was observed on the plates at any of the doses tested in either the presence or absence of S9-mix. - Remarks on result:
- other: other: Preliminary Toxicity Study
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Results for the negative controls (spontaneous mutation rates) were considered to be acceptable. These data are for concurrent untreated control plates performed on the same day as the Mutation Study.
The individual plate counts, the mean number of revertant colonies and the standard deviations, for the test material, positive and vehicle controls, both with and without metabolic activation, are presented in Table 3 and Table 4 for Experiment 1 and Table 5 and Table 6 for Experiment 2.
A history profile of vehicle and positive control values for 1999 and 2000 is presented in Table 7.
Table 3: Test Results: Experiment 1 - Without Metabolic Activation |
|||||||||||
TEST PERIOD | FROM: 07 SEPTEMBER 2001 | TO:10SEPTEMBER2001 | |||||||||
With or without S9-Mix | Test substance concentration (µg/plate) | Number of revertants (mean number of colonies per plate) | |||||||||
Base-pair substitution type | Frameshift type | ||||||||||
TA100 | TA1535 | WP2uvrA- | TA98 | TA1537 | |||||||
- | 0 | 67 | (72) 7.0# | 13 | (13) 1.0 | 31 | (23) 6.7 | 35 | (26) 7.9 | 12 | (12) 1.0 |
69 | 14 | 20 | 20 | 11 | |||||||
80 | 12 | 19 | 23 | 13 | |||||||
- | 15 | 81 | (75) 6.0 | 10 | (11) 1.0 | 22 | (20) 1.7 | 12 | (18) 6.0 | 6 | (8) 2.0 |
74 | 11 | 19 | 24 | 8 | |||||||
69 | 12 | 19 | 19 | 10 | |||||||
- | 50 | 111 | (85) 24.2 | 14 | (14) 3.0 | 19 | (21) 1.5 | 21 | (20) 1.2 | 14 | (11) 3.1 |
63 | 17 | 21 | 21 | 8 | |||||||
81 | 11 | 22 | 19 | 12 | |||||||
- | 150 | 80 | (82) 7.6 | 13 | (13) 1.5 | 19 | (16) 3.8 | 21 | (19) 4.0 | 8 | (10) 3.8 |
90 | 15 | 12 | 21 | 14 | |||||||
75 | 12 | 18 | 14 | 7 | |||||||
- | 500 | 62 | (70) 11.9 | 11 | (11) 0.0 | 19 | (18) 1.7 | 16 | (18) 2.9 | 16 | (10) 6.0 |
65 | 11 | 16 | 16 | 11 | |||||||
84 | 11 | 19 | 21 | 4 | |||||||
- | 1500 | 91 | (78) 15.9 | 13 | (13) 3.0 | 20 | (17) 4.6 | 22 | (23) 1.7 | 9 | (7) 2.1 |
82 | 16 | 20 | 22 | 6 | |||||||
60 | 10 | 12 | 25 | 5 | |||||||
- | 5000 | 34S | (28) 6.7 | 8S | (8) 1.5 | 19 | (17) 3.5 | 17S | (17) 2.5 | 0V | (0) 0.0 |
21S | 6S | 13 | 15S | 0V | |||||||
30S | 9S | 19 | 20S | 0V | |||||||
Positive controls | Name | ENNG | ENNG | ENNG | 4NQO | 9AA | |||||
Concentration (µg/plate) | 3 | 5 | 2 | 0.2 | 80 | ||||||
S9-Mix | |||||||||||
No. colonies per plate | 555 | (564) 19.2 | 676 | (527) 230.3 | 733 | (745) 12.5 | 149 | (144) 5.6 | 1456 | (1467) 170.3 | |
- | 586 | 262 | 745 | 138 | 1303 | ||||||
551 | 644 | 758 | 145 | 1643 | |||||||
ENNG N-ethyl-N'-nitro-N-nitrosoguanidine | |||||||||||
4NQO 4-Nitroquinoline-1-oxide | |||||||||||
9AA 9-Aminoacridine | |||||||||||
S Sparse bacterial background lawn | |||||||||||
V Very weak bacterial background lawn | |||||||||||
# Standard deviation |
Table 4: Test Results: Experiment 1 - With Metabolic Activation |
|||||||||||
TEST PERIOD | FROM: 07 SEPTEMBER 2001 | TO:10SEPTEMBER2001 | |||||||||
With or without S9-Mix | Test substance concentration (µg/plate) | Number of revertants (mean number of colonies per plate) | |||||||||
Base-pair substitution type | Frameshift type | ||||||||||
TA100 | TA1535 | WP2uvrA- | TA98 | TA1537 | |||||||
+ | 0 | 74 | (71) 10.3# | 12 | (12) 2.0 | 15 | (19) 5.1 | 23 | (30) 7.5 | 20 | (11) 8.2 |
60 | 10 | 18 | 38 | 9 | |||||||
80 | 14 | 25 | 29 | 4 | |||||||
+ | 15 | 77 | (75) 2.1 | 13 | (12) 1.0 | 20 | (20) 0.6 | 35 | (28) 7.0 | 10 | (6) 3.5 |
74 | 11 | 21 | 28 | 4 | |||||||
73 | 12 | 20 | 21 | 4 | |||||||
+ | 50 | 82 | (84) 8.2 | 14 | (14) 2.5 | 18 | (19) 4.0 | 27 | (30) 3.0 | 9 | (9) 1.5 |
77 | 16 | 23 | 33 | 7 | |||||||
93 | 11 | 15 | 30 | 10 | |||||||
+ | 150 | 78 | (83) 4.6 | 13 | (15) 1.5 | 10 | (20) 8.7 | 24 | (32) 7.4 | 12 | (11) 2.3 |
87 | 15 | 26 | 35 | 12 | |||||||
84 | 16 | 24 | 38 | 8 | |||||||
+ | 500 | 86 | (80) 14.9 | 18 | (14) 3.8 | 29 | (24) 5.0 | 27 | (29) 4.0 | 10 | (9) 3.1 |
91 | 11 | 19 | 34 | 6 | |||||||
63 | 12 | 23 | 27 | 12 | |||||||
+ | 1500 | 86 | (83) 2.9 | 11 | (11) 1.0 | 19 | (18) 1.0 | 34 | (34) 3.5 | 9 | (6) 2.5 |
81 | 12 | 18 | 38 | 4 | |||||||
81 | 10 | 17 | 31 | 6 | |||||||
+ | 5000 | 0V | (0) 0.0 | 8S | (7) 1.0 | 26 | (25) 3.1 | 26 | (28) 2.9 | 0V | (0) 0.0 |
0V | 6S | 28 | 26 | 0V | |||||||
0V | 7S | 22 | 31 | 0V | |||||||
Positive controls | Name | 2AA | 2AA | 2AA | BP | 2AA | |||||
Concentration (µg/plate) | 1 | 2 | 10 | 5 | 2 | ||||||
S9-Mix | |||||||||||
No. colonies per plate | 1908 | (1681)201.3 | 512 | (496) 14.2 | 762 | (787) 21.8 | 264 | (285) 21.5 | 243 | (266) 20.0 | |
+ | 1525 | 491 | 802 | 285 | 281 | ||||||
1609 | 485 | 797 | 307 | 273 | |||||||
2AA 2-Aminoanthracene | |||||||||||
BP Benzo(a)pyrene | |||||||||||
S Sparse bacterial background lawn | |||||||||||
V Very weak bacterial background lawn | |||||||||||
# Standard deviation |
Table 5: Test Results: Experiment 2 - Without Metabolic Activation |
|||||||||||
TEST PERIOD | FROM:18SEPTEMBER2001 | TO:21SEPTEMBER2001 | |||||||||
With or without S9-Mix | Test substance concentration (µg/plate) | Number of revertants (mean number of colonies per plate) | |||||||||
Base-pair substitution type | Frameshift type | ||||||||||
TA100 | TA1535 | WP2uvrA- | TA98 | TA1537 | |||||||
- | 0 | 123 | (135) 11.5# | 11 | (13) 1.5 | 18 | (18) 3.5 | 14 | (16) 2.8 | 12 | (11) 1.7 |
135 | 13 | 15 | C | 9 | |||||||
146 | 14 | 22 | 18 | 12 | |||||||
- | 15 | 138 | (134) 4.6 | 15 | (13) 4.0 | 24 | (24) 3.0 | 8 | (7) 1.7 | ||
129 | 15 | N/T | 27 | 5 | |||||||
135 | 8 | 21 | 8 | ||||||||
- | 50 | 108 | (117) 7.8 | 14 | (12) 2.1 | 19 | (18) 1.0 | 13 | (16) 5.8 | 10 | (11) 2.6 |
121 | 10 | 18 | 13 | 14 | |||||||
122 | 11 | 17 | 23 | 9 | |||||||
- | 150 | 121 | (133) 10.4 | 9 | (11) 2.5 | 14 | (17) 4.6 | 15 | (18) 3.1 | 9 | (9) 1.5 |
141 | 14 | 22 | 21 | 7 | |||||||
136 | 11 | 14 | 17 | 10 | |||||||
- | 500 | 125 | (131) 15.3 | 14 | (16) 8.2 | 15 | (17) 5.7 | C | (18) 1.4 | 5 | (9) 3.2 |
148 | 9 | 12 | 19 | 10 | |||||||
119 | 25 | 23 | 17 | 11 | |||||||
- | 1500 | 120 | (131) 11.5 | 10 | (8) 1.5 | 11 | (14) 4.4 | 10 | (13) 3.1 | 7 | (9) 2.1 |
143 | 7 | 12 | 16 | 11 | |||||||
130 | 8 | 19 | 12 | 10 | |||||||
- | 5000 | 58S | (37) 19.8 | 2S | (4) 1.5 | 18 | (21) 2.5 | 14 | (21) 7.5 | 0V | (0) 0.0 |
33S | 5S | 23 | 20 | 0V | |||||||
19S | 4S | 21 | 29 | 0V | |||||||
Positive controls | Name | ENNG | ENNG | ENNG | 4NQO | 9AA | |||||
Concentration (µg/plate) | 3 | 5 | 2 | 0.2 | 80 | ||||||
S9-Mix | |||||||||||
No. colonies per plate | 659 | (681) 33.0 | 189 | (228) 39.0 | 570 | (691) 113.9 | 125 | (134) 12.1 | 1217 | (1372) 248.0 | |
- | 665 | 228 | 708 | 130 | 1241 | ||||||
719 | 267 | 796 | 148 | 1658 | |||||||
ENNG N-ethyl-N'-nitro-N-nitrosoguanidine | |||||||||||
4NQO 4-Nitroquinoline-1-oxide | |||||||||||
9AA 9-Aminoacridine | |||||||||||
C Contaminated | |||||||||||
N/T Not tested at this dose level | |||||||||||
S Sparse bacterial background lawn | |||||||||||
V Very weak bacterial background lawn | |||||||||||
# Standard deviation |
Table 6: Test Results: Experiment 2 - With Metabolic Activation |
||||||||||||
TEST PERIOD | FROM: 18 SEPTEMBER 2001 | TO:21SEPTEMBER2001 | ||||||||||
With or without S9-Mix | Test substance concentration (µg/plate) | Number of revertants (mean number of colonies per plate) | ||||||||||
Base-pair substitution type | Frameshift type | |||||||||||
TA100 | TA1535 | WP2uvrA- | TA98 | TA1537 | ||||||||
+ | 0 | 155 | (157) 11.7# | 12 | (10) 2.9 | 20 | (21) 1.2 | 32 | (29) 7.0 | 12 | (13) 2.1 | |
147 | 12 | 22 | 21 | 15 | ||||||||
170 | 7 | 22 | 34 | 11 | ||||||||
+ | 15 | 150 | (148) 4.9 | 9 | (12) 3.6 | 18 | (24) 6.6 | 19 | (17) 3.2 | |||
142 | 11 | N/T | 23 | 18 | ||||||||
151 | 16 | 31 | 13 | |||||||||
+ | 50 | 147 | (137) 13.8 | 11 | (9) 2.1 | 15 | (20) 6.2 | 28 | (27) 1.5 | 16 | (18) 2.5 | |
142 | 7 | 27 | 27 | 21 | ||||||||
121 | 10 | 18 | 25 | 18 | ||||||||
+ | 150 | 132 | (137) 14.2 | 10 | (11) 3.2 | 28 | (25) 2.9 | 32 | (28) 5.3 | 25 | (18) 6.5 | |
126 | 15 | 23 | 22 | 12 | ||||||||
153 | 9 | 23 | 30 | 18 | ||||||||
+ | 500 | 145 | (139) 9.0 | 9 | (8) 1.2 | 26 | (25) 3.6 | 27 | (26) 3.2 | 9 | (11) 2.5 | |
129 | 9 | 28 | 28 | 11 | ||||||||
144 | 7 | 21 | 22 | 14 | ||||||||
+ | 1500 | 110 | (115) 5.0 | 9 | (7) 1.5 | 15 | (18) 3.8 | 15 | (19) 5.5 | 10 | (13) 2.5 | |
114 | 6 | 16 | 16 | 13 | ||||||||
120 | 7 | 22 | 25 | 15 | ||||||||
+ | 5000 | 0V | (0) 0.0 | 0V | (0) 0.0 | 22 | (22) 5.5 | 22 | (15) 6.4 | 0T | (0) 0.0 | |
0V | 0V | 17 | 11 | 0T | ||||||||
0V | 0V | 28 | 11 | 0T | ||||||||
Positive controls | Name | 2AA | 2AA | 2AA | BP | 2AA | ||||||
Concentration (µg/plate) | 1 | 2 | 10 | 5 | 2 | |||||||
S9-Mix | ||||||||||||
No. colonies per plate | 1454 | (1440) 33.9 | 471 | (460) 9.6 | 1070 | (1203) 137.8 | 266 | (312) 41.5 | 273 | (297) 32.5 | ||
+ | 1401 | 453 | 1193 | 347 | 334 | |||||||
1464 | 456 | 1345 | 322 | 284 | ||||||||
2AA 2-Aminoanthracene | ||||||||||||
BP Benzo(a)pyrene |
N/T Not tested at this dose level | |||||||||||
T Toxic, no bacterial background lawn | |||||||||||
V Very weak bacterial background lawn | |||||||||||
# Standard deviation |
The test material caused a visible reduction in the growth of the bacterial background lawn to the majority of the Salmonella tester strains, both with and without S9-mix, at 5000 μg/plate. No toxicity was observed to Escherichia coli strain WP2uvrA-. The test material was, therefore, tested up to the maximum recommended dose level of 5000 μg/plate. No test material precipitate was observed on the plates at any of the doses tested in either the presence or absence of S9-mix.
No significant increases in the frequency of revertant colonies were recorded for any of the bacterial strains, with any dose of the test material, either with or without metabolic activation.
All of the positive control chemicals used in the test induced marked increases in the frequency of revertant colonies thus confirming the activity of the S9-mix and the sensitivity of the bacterial strains.
Table 7: history profile of vehicle and positive control values |
||||||||||||||||||
COMBINED VEHICLE AND UNTREATED CONTROL VALUES 1999 | ||||||||||||||||||
Strain | TA100 | TA98 | TA1535 | TA1538 | TA1537 | WP2uvrA- | TA102 | |||||||||||
S9-Mix | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | ||||
Mean | 102 | 107 | 24 | 31 | 22 | 16 | 13 | 19 | 11 | 17 | 23 | 27 | 263 | 298 | ||||
SD | 19 | 20 | 6 | 7 | 6 | 4 | 5 | 5 | 3 | 4 | 5 | 6 | 42 | 32 | ||||
Min | 57 | 63 | 10 | 12 | 10 | 7 | 5 | 8 | 3 | 5 | 10 | 11 | 188 | 222 | ||||
Max | 179 | 186 | 46 | 56 | 40 | 35 | 32 | 31 | 25 | 26 | 52 | 46 | 352 | 363 | ||||
Values | 751 | 592 | 646 | 510 | 645 | 488 | 57 | 31 | 634 | 481 | 641 | 495 | 89 | 37 | ||||
POSITIVE CONTROL VALUES1999 | ||||||||||||||||||
Strain | TA100 | TA98 | TA1535 | TA1538 | TA1537 | WP2uvrA- | TA102 | |||||||||||
S9-Mix | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | ||||
Mean | 549 | 1019 | 146 | 312 | 368 | 245 | 327 | 446 | 1017 | 345 | 787 | 598 | 882 | 737 | ||||
SD | 176 | 378 | 32 | 129 | 237 | 60 | 157 | 184 | 307 | 152 | 251 | 232 | 186 | 117 | ||||
Min | 238 | 406 | 95 | 113 | 104 | 123 | 113 | 215 | 350 | 112 | 200 | 208 | 583 | 509 | ||||
Max | 1170 | 2060 | 290 | 717 | 1229 | 467 | 653 | 837 | 2031 | 870 | 1760 | 1294 | 1673 | 1261 | ||||
Values | 161 | 160 | 162 | 160 | 158 | 157 | 27 | 27 | 159 | 158 | 153 | 152 | 52 | 51 | ||||
COMBINED VEHICLE AND UNTREATED CONTROL VALUES2000 | ||||||||||||||||||
Strain S9-Mix | TA100 | TA1535 | WP2uvrA- | TA102 | TA98 | TA1537 | TA1538 | WP2uvrA-p1im101 | TA97a | |||||||||
-S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 +S | 9-S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | ||
Mean | 115 | 118 | 22 | 16 | 22 | 24 | 284 31; | > 23 | 32 | 12 | 16 | 14 | 31 | 222 | 198 | 102 | 125 | |
SD | 22 | 22 | 5 | 4 | 5 | 6 | 41 35 | 6 | 6 | 4 | 4 | 6 | 3 | 99 | 42 | 14 | 4 | |
Min | 63 | 63 | 8 | 9 | 8 | 10 | 193 22/ | I11 | 13 | 4 | 8 | 8 | 29 | 113 | 168 | 82 | 122 | |
Max | 198 | 181 | 40 | 31 | 45 | 47 | 38137- | J55 | 63 | 25 | 27 | 21 | 33 | 377 | 228 | 123 | 127 | |
Values | 801 | 621 | 761 | 588 | 706 | 540 | 149 81 | 764 | 594 | 749 | 575 | 6 | 2 | 5 | 2 | 6 | 2 | |
POSITIVE CONTROL VALUES 2000 | ||||||||||||||||||
Strain S9-Mix | TA100 | TA1535 | WP2i | vrA- | TA102 | TA | 98 | TA15 | 37 | TA | 1538 | WP2u p1m | vrA-01 | TA | 97a | |||
-S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 +S | 9-S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | ||
Mean | 488 | 1620 | 382 | 278 | 663 | 664 | 877 79 | 4 138 | 259 | 1071 | 466 | 225 | 607 | 2089 | 1389 | 261 | 685 | |
SD | 137 | 490 | 260 | 89 | 243 | 212 | 137 12 | 3 34 | 70 | 327 | 121 | 28 | 40 | 175 | 967 | 1 | 141 | |
Min | 234 | 443 | 125 | 128 | 203 | 185 | 522 38 | 8 89 | 129 | 290 | 191 | 193 | 568 | 1965 | 705 | 260 | 585 | |
Max | 1190 | 3079 | 1843 | 630 | 1520 | 1534 | 1161 109 | 0 262 | 506 | 2160 | 768 | 245 | 648 | 2213 | 2073 | 261 | 785 | |
Values | 172 | 172 | 172 | 170 | 166 | 166 | 69 7 | 0 173 | 172 | 171 | 170 | 3 | 3 | 2 | 2 | 2 | 2 | |
SD=Standard deviation | ||||||||||||||||||
Min =Minimal value | ||||||||||||||||||
Max=Maximum value |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative without metabolic activation
negative with metabolic activation
The study was performed according to the OECD Guideline 471, EU Method B13/14 and EPA OPPTS 870.5100 without deviations and considered to be of the highest quality (reliability Klimisch 1). The vehicle and the positive control substances fulfilled validity criteria of the test system. The Salmonella/microsome test, employing doses up to 5000 µg per plate, showed Caprolactam disulphide to produce no bacteriotoxic effects in Escherichia coli strain WP2uvrA-. A Cytotoxic effect was seen in the majority of the Salmonella strains at 5000 µg/plate. The test material did not induce significant increases in the frequency of revertant colonies in the bacterial strains used. No indications of mutagenic effects of Caprolactam disulphide could be found at assessable doses up to 5000 µg per plate in any of the strains tested. The test material was considered to be non-mutagenic under the conditions of this test. - Executive summary:
Caprolactam disulfide was investigated using the Salmonella/microsome test for point mutagenic effects in doses up to 5000 µg per plate on four Salmonella typhimurium LT2 mutants (TA 1535, TA 1537, TA 100 and TA 98 ) and Escherichia coli strain WP2uvrA-. The study was performed according to the OECD Guideline 471, EU Method B13/14 and EPA OPPTS 870.5100 without deviations and considered to be of the highest quality (reliability Klimisch 1). The bacteria were treated with the test material using the Ames plate incorporation method at up to six dose levels, in triplicate, both with and without the addition of a rat liver homogenate metabolising system (10% liver S9 in standard cofactors). The dose range was determined in a preliminary toxicity assay and was 15 to 5000 μg/plate in the first experiment. The experiment was repeated on a separate day using a similar dose range to Experiment 1, fresh cultures of the bacterial strains and fresh test material formulations. An additional dose (15 μg/plate) was used to allow for the toxicity of the test material and to ensure there were a minimum of four non-toxic doses plated out. Results for the negative controls (spontaneous mutation rates) were considered to be acceptable. The vehicle (dimethyl sulphoxide) control plates gave counts of revertant colonies within the normal range. The positive controls N-ethyl-N'-nitro-N-nitrosoguanidine(ENNG, 9-Aminoacridine (9AA) and 4-Nitroquinoline-1-oxide (4NQO) had a marked mutagenic effect, as was seen by a biologically relevant increase in mutant colonies compared to the corresponding negative controls. So all of the positive control chemicals used in the test induced marked increases in the frequency of revertant colonies, both with and without metabolic activation. Thus, the sensitivity of the assay and the efficacy of the S9-mix were validated. The test material caused a visible reduction in the growth of the bacterial background lawn to the majority of the Salmonella tester strains, both with and without S9 -mix, at 5000 μg/plate. No toxicity was observed to Escherichia coli strain WP2uvrA-. The test material was, therefore, tested up to the maximum recommended dose level of 5000 μg/plate. No test material precipitate was observed on the plates at any of the doses tested in either the presence or absence of S9-mix. No significant increases in the frequency of revertant colonies were recorded for any of the bacterial strains, with any dose of the test material, either with or without metabolic activation. In conclusion, the test material was considered to be non-mutagenic under the conditions of this test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.